Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Income from Continuing Operations (2020 - 2025)

Medicale's Income from Continuing Operations history spans 6 years, with the latest figure at 8654.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 48.74% year-over-year to 8654.0; the TTM value through Sep 2025 reached 33652.0, up 42.19%, while the annual FY2025 figure was 33652.0, 42.19% up from the prior year.
  • Income from Continuing Operations reached 8654.0 in Q3 2025 per MCLE's latest filing, down from 3575.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3575.0 in Q2 2025 to a low of 19307.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 10216.58, with a median of 8654.0 recorded in 2025.
  • Peak YoY movement for Income from Continuing Operations: crashed 121.56% in 2023, then soared 65.83% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 18096.0 in 2021, then skyrocketed by 51.85% to 8714.0 in 2022, then crashed by 121.56% to 19307.0 in 2023, then rose by 22.33% to 14995.0 in 2024, then soared by 42.29% to 8654.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Income from Continuing Operations are 8654.0 (Q3 2025), 3575.0 (Q2 2025), and 6428.0 (Q1 2025).